News and Events

ChemBridge to Attend and Exhibit at CHI Discovery on Target, Boston, MA, Sept. 25-27, 2018

San Diego, CA, USA, July 25, 2017

The CHI Discovery on Target 2018 Conference and Exhibition will be held in Boston, MA, September 25-28, 2018. Discovery on Target, produced and organized by Cambridge Healthtech Institute (CHI), is the industry’s pre-eminent event on novel drug targets and will bring together over 1,300 drug discovery professionals in Boston, MA, this September 25-28, 2018. The event brings forth current and emerging hot targets, technologies and validation strategies for the development of novel small molecules and biologics. The conference includes presentations and and short courses on topics including:

  • Small Molecules for Cancer Immunotherapy
  • Targeting the Ubiquitin-Proteasome System
  • CNS and Neurodegenerative Targets
  • Constrained Peptides and Macrocyclics
  • Kinase Inhibitor Discovery
  • GPCR-Based Drug Discovery
  • Lead Generation Strategies
  • Targeting the Microbiome
  • Antivirals: Targeting HBV and Beyond

ChemBridge will be present to discuss our screening compound, macrocycle, and building block offerings for small molecule drug discovery and chemical biology research including:

  • Our stock of more than 1.3 million small molecule screening compounds including sp3-enriched screening compounds with more 3-dimensional structure
  • Our Macrocycle Library compounds and the Macrocycle CNS Subset
  • Diversity libraries including the DIVERSet-CL and DIVERSet-EXP Libraries
  • Targeted libraries and biased screening libraries for kinase, ion channel, GPCR, nuclear receptor and CNS research
  • Fragment Library compounds for fragment based drug discovery
  • Our stock of more than 14,000 building blocks / reagents for medicinal chemists

Please stop by the ChemBridge booth #513 in the exhibit hall or contact Duncan Beniston, Executive Director Sales and Marketing, at duncan@chembridge.com to arrange a meeting.

back to top